Ledger.Open graph →
SEC Form D · Amendment · filed April 20, 2017

M3 Biotechnology, Inc

Offering
$11.0M
Sold
$10.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Michael M. Montgomery · Seattle, WADirectorBruce Montgomery · Seattle, WADirectorJoseph W. Harding · Seattle, WADirectorLeen Kawas · Seattle, WAExec · DirectorJohn Fluke · Seattle, WAExec · DirectorConifer Management, L.L.C · New York, NYDirectorNiraj F. Mehta · Oakland, CADirectorTimothy M. Miller · Bellefonte, PAExec · DirectorGregory Alexander · New York, NYExec · Director[Entity] Lasalle Income & Growth Fund Viii GP, L.L.C · CHICAGO, ILDirectorMarc A. Schneebaum · Madison, WIExec · DirectorAndrew E. Ferrara · Madison, WIDirectorJames H. Schmidt · Evans City, PAExec · DirectorTimothy F. Keaney · Oakland, CADirectorGlobal Pacific Funding, LLC · Phoenix, AZDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗